Do patients with fibromyalgia syndrome and healthy people differ in their opinions on placebo effects in routine medical care?

被引:0
|
作者
van Lennep, Johan P. A. [1 ,2 ]
Meijer, Simone [1 ,2 ]
Karacaoglu, Merve [1 ,2 ]
Rippe, Ralph [3 ]
Peerdeman, Kaya J. [1 ,2 ]
van Middendorp, Henriet [1 ,2 ]
Evers, Andrea W. M. [1 ,2 ,4 ,5 ,6 ]
机构
[1] Leiden Univ, Fac Social & Behav Sci, Hlth Med & Neuropsychol Unit, Wassenaarseweg 52, NL-2333 AK Leiden, Netherlands
[2] Ctr Interdisciplinary Placebo Studies Leiden, Leiden, Netherlands
[3] Leiden Univ, Fac Social Sci, Dept Methodol & Stat, Leiden, Netherlands
[4] Leiden Univ, Dept Psychiat, Med Ctr, Leiden, Netherlands
[5] Leiden Univ, Tech Univ Delft, Med Delta, Delft, Netherlands
[6] Erasmus Univ, Leiden, Netherlands
关键词
behavioral medicine; fibromyalgia; RHEUMATOID-ARTHRITIS; CLINICAL-PRACTICE; PAIN MANAGEMENT; ACCEPTABILITY; DECEPTION; NOCEBO; MECHANISMS; PERCEPTIONS; PERSONALITY; ATTITUDES;
D O I
10.1111/papr.70000
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Objectives: Placebo effects can relieve acute and chronic pain in both research and clinical treatments by learning mechanisms. However, the application of placebo-based treatment strategies in routine medical care is questioned. The current study investigated the opinions of patients with fibromyalgia and healthy controls regarding learning of placebo effects and their practical applications. Method: An online survey asked 158 age- and sex-matched adult patients and controls (79 per group) to rate the perceived influence of various placebo learning mechanisms on pain relief, and the acceptability and perceived effectiveness of placebo-based strategies (open-label, closed-label, dose-extending, and treatment-enhancing strategies). Respondents' knowledge about placebo effects was obtained through a 7-item quiz. Results: The groups did not differ in the perceived influence of placebo learning mechanisms on pain relief (p = 0.217). Controls considered closed-label and treatment-enhancing strategies more acceptable than patients (p = 0.003 and p < 0.001), whereas controls perceived all strategies more effective. In both groups, closed-label strategies were significantly less acceptable than any other strategy (p-values < 0.001), and treatment-enhancing or dose-extending strategies were most acceptable. Higher acceptability was predicted by higher perceived effectiveness ratings (p < 0.001). Also, increased placebo knowledge was related to higher acceptability (p = 0.03) and perceived effectiveness (p < 0.001). Discussion: This survey suggests that both the medical history of patients and knowledge about placebo effects affect the acceptability and perceived effectiveness of placebo-based strategies. Furthermore, strategies that are transparent, assumed effective, or combined with existing medical treatments are deemed most acceptable. Keeping these factors in mind is essential for the clinical implementation of placebo-based strategies in routine medical care.
引用
收藏
页数:13
相关论文
共 6 条
  • [1] Neural effects of placebo analgesia in fibromyalgia patients and healthy individuals
    Frangos, Eleni
    Ceko, Marta
    Wang, Binquan
    Richards, Emily A.
    Gracely, John L.
    Colloca, Luana
    Schweinhardt, Petra
    Bushnell, M. Catherine
    PAIN, 2021, 162 (02) : 641 - 652
  • [2] Effects of topical O24 essential oils on patients with fibromyalgia syndrome: A randomized, placebo controlled pilot study
    Ko, Gordon D.
    Hum, Annie
    Traitses, George
    Berbrayer, David
    JOURNAL OF MUSCULOSKELETAL PAIN, 2007, 15 (01): : 11 - 19
  • [3] Effects of mirtazapine on quality of life of Thai patients with fibromyalgia syndrome: a double-blind, randomized, placebo-controlled trial
    Suttiruksa, Saithip
    Yeephu, Suwimon
    Prateepavanich, Pradit
    Suthisisang, Chuthamanee
    ASIAN BIOMEDICINE, 2016, 10 (05) : 435 - 445
  • [4] What Do Placebo and Nocebo Effects Have to Do With Health Equity? The Hidden Toll of Nocebo Effects on Racial and Ethnic Minority Patients in Clinical Care
    Yetman, Hailey E.
    Cox, Nevada
    Adler, Shelley R.
    Hall, Kathryn T.
    Stone, Valerie E.
    FRONTIERS IN PSYCHOLOGY, 2021, 12
  • [5] Effects of Bedtime Very Low Dose Cyclobenzaprine on Symptoms and Sleep Physiology in Patients with Fibromyalgia Syndrome: A Double-blind Randomized Placebo-controlled Study
    Moldofsky, Harvey
    Harris, Herbert W.
    Archambault, W. Tad
    Kwong, Terence
    Lederman, Seth
    JOURNAL OF RHEUMATOLOGY, 2011, 38 (12) : 2653 - 2663
  • [6] Effects of Sodium Oxybate on Sleep Physiology and Sleep/Wake-related Symptoms in Patients with Fibromyalgia Syndrome: A Double-blind, Randomized, Placebo-controlled Study
    Moldofsky, Harvey
    Inhaber, Neil H.
    Guinta, Diane R.
    Alvarez-Horine, Sarah B.
    JOURNAL OF RHEUMATOLOGY, 2010, 37 (10) : 2156 - 2166